Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove - Wikidata - wikimedia - TriplyDB

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

http://www.wikidata.org/entity/Q23917120

about

sameAs

Gene-environment interaction from international cohorts: impact on development and evolution of occupational and environmental lung and airway disease Research to practice implications of high-risk genotypes for beryllium sensitization and disease Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan T cell recognition of beryllium Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation Chronic Beryllium Disease: revealing the role of beryllium ion and small peptides binding to HLA-DP2 Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway.The orthologs of HLA-DQ and -DP genes display abundant levels of variability in macaque species.Clinical tool for disease phenotyping in granulomatous lung disease.Beryllium disease among construction trade workers at department of Energy nuclear sites

P2860

Q26866279-5EBCD757-27B1-4CD7-ADC4-EF729A7966BE Q27908555-5E85DE1C-1BAE-40A4-B856-287153FD0181 Q28388529-6646F67F-A108-49A9-942E-72AC9D0ECA0D Q28393881-5D27100A-CD05-477D-808C-26CF9A2B4463 Q28396954-5154C9C0-DE2F-4EDF-BB6F-9C4A3BC16D8B Q28397104-E0F2A0FC-7FB1-49BC-A7E3-D0C7E458F1D8 Q38384482-C1F73A10-D4EC-413B-A643-F408B4C1E281 Q39059159-95A3DC8A-BF29-45BE-ADB5-1904BF52DDBF Q41988716-8B16ECE0-F755-4F5E-85C1-16CA55BA25C7 Q46472738-C669C37D-C560-4C65-A356-CA0099C9B51C Q47103980-9F2110CD-99B9-4F2D-B7A3-ECB5E9347110 Q56156664-158A6468-8C27-4A91-99DB-8AEF2F06979C

P2860

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

http://www.wikidata.org/entity/Q23917120

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@ast

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@en

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@en-gb

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@nl

type

label

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@ast

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@en

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@en-gb

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@nl

prefLabel

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@ast

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@en

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@en-gb

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@nl

P1433

Q23917120-6AF69715-F8AE-47A3-A034-4EA83B1687F5

P1476

Q23917120-DCEFBD1C-A57A-4238-B18F-B7ECDF07393A

P2093

Q23917120-001084FE-8743-4B26-B438-AC888C8BD847

Q23917120-042C6C1E-B09A-45FE-B0C7-3370AE06C179

Q23917120-16DA7781-3093-4D49-AD81-3C44B0EC5382

Q23917120-39C4B053-8347-4D77-AD2D-A6ABC778D34F

Q23917120-491E189A-C499-49B7-893F-586775EE5224

Q23917120-4F67DCD4-7932-4F0E-B1C4-AA346510EDCC

Q23917120-5E4B07E5-5B30-40D7-9E5A-A3838AF96DDB

Q23917120-8857F04A-75B7-45D7-823E-EDD3DB21C65B

Q23917120-8E95D4EB-77E3-44C7-B5E3-0779E56C6EBD

Q23917120-95A3DC96-51B9-46C7-9B94-B5CF9D2A6A54

P2860

Q23917120-03E1F1ED-2AE6-4C05-A5D0-4C3F891DFB22

Q23917120-0401F4C1-6300-4E23-B136-EDDDFB296148

Q23917120-14699BB8-2B89-4458-8248-960AF6C56D1D

Q23917120-1C8E1BAB-042D-4C0C-B3E2-E10BACC10F3E

Q23917120-223130DA-5088-4698-B18F-E672F1647953

Q23917120-292C8762-E59F-4358-A22A-17BB7E90F024

Q23917120-34AB9AD4-BBE3-4D7C-BF10-1E6E9E5C837D

Q23917120-4246AE60-86D4-4FFF-928D-4A03F01A8A72

Q23917120-4438C4AD-007B-4A19-A75D-5AB01532D6F7

Q23917120-4537F79C-CACD-438C-9706-5FF2772235F8

P2880

Q23917120-85F6DC23-6E94-4A24-99B4-886A00202CC7

P304

Q23917120-3E484C29-4490-43CB-BC90-744D261BBB20

P31

Q23917120-20D5430A-3A81-4B64-96EF-C5F253F286F0

P356

Q23917120-F3BF5071-4682-47A6-99C9-6C4F52C50C0B

P407

Q23917120-742B13B9-C48D-4992-B37C-E0DB2F83FD9D

P433

Q23917120-A0269C9F-6D5A-4C22-A84C-65A3F9FA218D

P478

Q23917120-1D8492AC-B995-4963-AB23-121E433DF39A

P50

Q23917120-05B99CDA-F50A-45BB-A9D3-0A61E1C52C5F

P577

Q23917120-190E0914-1CB9-40E4-9637-50B8DCD72575

P5875

Q23917120-D60B477B-5320-4EEB-A151-DF28C0553663

P698

Q23917120-873969B0-1C34-4ECE-9D65-73814769D968

P859

Q23917120-F9339AC2-CF8F-438D-B3AF-D31E92A91641

P921

Q23917120-054674C2-7EEA-4554-B1D3-855DB35B2037

Q23917120-1251EA7E-392F-4F2B-9529-38AC696A95A7

Q23917120-38693C0E-5D33-44EF-83BC-7E60CD7A34C4

Q23917120-63744A3F-C2F0-42BB-8767-E2F1C481515D

Q23917120-A652240A-CDEB-4BE1-9250-03D370BF8FB1

Q23917120-EC9118B3-8367-4F2B-A72F-F38ED1B2B58D

Q23917120-FB6803DB-82F0-4ECB-A049-1CB621D7DF95

P932

Q23917120-6BA46A6A-7D38-4D8D-8C33-7574AC3EEDB3

P356

JIMMUNOL.1200798

P1433

Journal of Immunology

P1476

Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove

@en

P2093

Andrew P Fontenot

http://www.w3.org/2001/XMLSchema#string

Christine R Schuler

http://www.w3.org/2001/XMLSchema#string

Dana M Dabelea

http://www.w3.org/2001/XMLSchema#string

Erin C McCanlies

http://www.w3.org/2001/XMLSchema#string

Lisa A Maier

http://www.w3.org/2001/XMLSchema#string

Lori J Silveira

http://www.w3.org/2001/XMLSchema#string

Margaret M Mroz

http://www.w3.org/2001/XMLSchema#string

Matthew Strand

http://www.w3.org/2001/XMLSchema#string

Michael V Van Dyke

http://www.w3.org/2001/XMLSchema#string

Natalie Bowerman

http://www.w3.org/2001/XMLSchema#string

P2860

DNA-sequence determination of exon 2 of a novel HLA-DPB1 allele, HLA-DPB1*0403

Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers

The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization

HLA-DPB1 and chronic beryllium disease: a HuGE review

Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease

HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity

Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk

Influence of MHC CLASS II in susceptibility to beryllium sensitization and chronic beryllium disease

Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease

Crystal structure of HLA-DP2 and implications for chronic beryllium disease

P2880

20041803

http://www.w3.org/2001/XMLSchema#string

P304

4014-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1200798

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230843519

http://www.w3.org/2001/XMLSchema#string

P698

22972925

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

L-glutamic acid

P932

4347851

http://www.w3.org/2001/XMLSchema#string